FindTrial
Sign In

Evaluation of Transfusion Appropriateness for Patients Blood Management: Utilizing customized medical data from Health Insurance Review & Assessment Service(HIRA)

Evaluation of Transfusion Appropriateness for Patients Blood Management: Utilizing customized medical data from Health Insurance Review & Assessment Service(HIRA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011245
Enrollment
1555248
Registered
2025-12-03
Start date
2022-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients aged 20 years or older residing in the Republic of Korea who underwent surgery for colorectal cancer, stomach cancer, gynecological cancer, liver cancer, or pancreatic cancer between 2010 and 2019.

Exclusion criteria

Exclusion criteria: Patients who underwent overlapping surgery for the target disease

Design outcomes

Primary

MeasureTime frame
transfusion parameter—

Secondary

MeasureTime frame
comorbidity—

Countries

Korea, Republic of

Contacts

Public ContactYoung-Woo Kim

National Cancer Center

youngwookim@ncc.re.kr+82-31-920-1635

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026